Tapewire

Nasdaq · USD

ANAB

ANAPTYSBIO, INC

Export transactions ↓
Tapewire entity
4640
SEC CIK
0001370053
Parsed reports
295

Last 12 months

Inside the activity.

0 purchase rows · 42 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 2025010
Jan 2026017
Feb 202601
Mar 2026013
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 15, 2026 Filed Jan 16, 2026 18:05 UTC SaleCommon Stock 9,290 $48.12 $446,999.50
Disclosure

SEC source: 0001631486-26-000002 · form4-01162026_010101.xml · nonDerivative · entry 2

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,640

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.595 to $48.54 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 15, 2026 Filed Jan 16, 2026 18:05 UTC Exercise / conversionCommon Stock 11,000 $26.11 $287,210.00
Disclosure

SEC source: 0001631486-26-000002 · form4-01162026_010101.xml · nonDerivative · entry 1

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,930

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 08, 2026 Filed Jan 10, 2026 00:16 UTC
Lizzul Paul F.Chief Medical Officer
SaleCommon Stock 3,650 $44.71 $163,191.50
Disclosure

SEC source: 0001711462-26-000006 · form4-01102026_120159.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,088

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 08, 2026 Filed Jan 10, 2026 00:12 UTC
Faga DanielDirector · President, CEO
SaleCommon Stock 14,281 $44.71 $638,503.51
Disclosure

SEC source: 0001673528-26-000006 · form4-01102026_120114.xml · nonDerivative · entry 2

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 479,344

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 08, 2026 Filed Jan 9, 2026 19:13 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 2,210 $44.71 $98,809.10
Disclosure

SEC source: 0001239648-26-000006 · form4-01102026_120125.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,835

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 08, 2026 Filed Jan 10, 2026 00:14 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
SaleCommon Stock 2,515 $44.71 $112,445.65
Disclosure

SEC source: 0001276840-26-000006 · form4-01102026_120148.xml · nonDerivative · entry 2

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,852

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:11 UTC
Lizzul Paul F.Chief Medical Officer
SaleCommon Stock 2,235 $45.11 $100,820.85
Disclosure

SEC source: 0001711462-26-000004 · form4-01082026_090121.xml · nonDerivative · entry 2

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,213

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:10 UTC
Faga DanielDirector · President, CEO
SaleCommon Stock 9,202 $45.11 $415,102.22
Disclosure

SEC source: 0001673528-26-000004 · form4-01082026_090111.xml · nonDerivative · entry 2

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466,787

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 500 $47.23 $23,615.00
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 5

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,157

F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 1,841 $46.13 $84,925.51
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 4

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,657

F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.96 to $46.83 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 5,281 $45.38 $239,672.38
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,498

F3 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person dated April 11, 2025.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.87 to $45.835 per share, inclusive. The reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
SaleCommon Stock 2,017 $45.11 $90,986.87
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 2

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,779

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 07, 2026 Filed Jan 8, 2026 21:08 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
SaleCommon Stock 1,908 $45.11 $86,069.88
Disclosure

SEC source: 0001276840-26-000004 · form4-01082026_090154.xml · nonDerivative · entry 2

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,667

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
January 07, 2026 Filed Jan 10, 2026 00:16 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 8,525 $0.00 $0.00
Disclosure

SEC source: 0001711462-26-000006 · form4-01102026_120159.xml · derivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,575

Underlying: Common Stock · 8,525 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2026 Filed Jan 10, 2026 00:16 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 8,525 Not disclosed Not disclosed
Disclosure

SEC source: 0001711462-26-000006 · form4-01102026_120159.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 07, 2026 Filed Jan 10, 2026 00:12 UTC
Faga DanielDirector · President, CEO
Exercise / conversionRestricted Stock Unit · Derivative 26,838 $0.00 $0.00
Disclosure

SEC source: 0001673528-26-000006 · form4-01102026_120114.xml · derivative · entry 3

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,512

Underlying: Common Stock · 26,838 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2026 Filed Jan 10, 2026 00:12 UTC
Faga DanielDirector · President, CEO
Exercise / conversionCommon Stock 26,838 Not disclosed Not disclosed
Disclosure

SEC source: 0001673528-26-000006 · form4-01102026_120114.xml · nonDerivative · entry 1

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 493,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 19:13 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 5,888 $0.00 $0.00
Disclosure

SEC source: 0001239648-26-000006 · form4-01102026_120125.xml · derivative · entry 3

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,662

Underlying: Common Stock · 5,888 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2026 Filed Jan 9, 2026 19:13 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 5,888 Not disclosed Not disclosed
Disclosure

SEC source: 0001239648-26-000006 · form4-01102026_120125.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,045

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 07, 2026 Filed Jan 10, 2026 00:14 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 6,700 $0.00 $0.00
Disclosure

SEC source: 0001276840-26-000006 · form4-01102026_120148.xml · derivative · entry 3

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,100

Underlying: Common Stock · 6,700 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 7, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 07, 2026 Filed Jan 10, 2026 00:14 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 6,700 Not disclosed Not disclosed
Disclosure

SEC source: 0001276840-26-000006 · form4-01102026_120148.xml · nonDerivative · entry 1

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,367

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:03 UTC GrantRestricted Stock Unit · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001715429-26-000001 · form4-01082026_090158.xml · derivative · entry 2

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:03 UTC GrantStock Option (right to buy) · Derivative 5,500 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001715429-26-000001 · form4-01082026_090158.xml · derivative · entry 1

Ware J. Anthony · CIK 0001715429 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires 2036-01-05

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:11 UTC
Lizzul Paul F.Chief Medical Officer
GrantStock Option (right to buy) · Derivative 29,000 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001711462-26-000004 · form4-01082026_090121.xml · derivative · entry 5

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

Underlying: Common Stock · 29,000 shares

Expires 2036-01-05

F5 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:11 UTC
Lizzul Paul F.Chief Medical Officer
GrantRestricted Stock Unit · Derivative 21,400 $0.00 $0.00
Disclosure

SEC source: 0001711462-26-000004 · form4-01082026_090121.xml · derivative · entry 4

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,400

Underlying: Common Stock · 21,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:11 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionRestricted Stock Unit · Derivative 6,145 $0.00 $0.00
Disclosure

SEC source: 0001711462-26-000004 · form4-01082026_090121.xml · derivative · entry 3

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,145

Underlying: Common Stock · 6,145 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:11 UTC
Lizzul Paul F.Chief Medical Officer
Exercise / conversionCommon Stock 6,145 Not disclosed Not disclosed
Disclosure

SEC source: 0001711462-26-000004 · form4-01082026_090121.xml · nonDerivative · entry 1

Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:10 UTC
Faga DanielDirector · President, CEO
GrantStock Option (right to buy) · Derivative 133,400 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001673528-26-000004 · form4-01082026_090111.xml · derivative · entry 5

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,400

Underlying: Common Stock · 133,400 shares

Expires 2036-01-05

F5 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:10 UTC
Faga DanielDirector · President, CEO
GrantRestricted Stock Unit · Derivative 98,600 $0.00 $0.00
Disclosure

SEC source: 0001673528-26-000004 · form4-01082026_090111.xml · derivative · entry 4

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,600

Underlying: Common Stock · 98,600 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:10 UTC
Faga DanielDirector · President, CEO
Exercise / conversionRestricted Stock Unit · Derivative 17,850 $0.00 $0.00
Disclosure

SEC source: 0001673528-26-000004 · form4-01082026_090111.xml · derivative · entry 3

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,850

Underlying: Common Stock · 17,850 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:10 UTC
Faga DanielDirector · President, CEO
Exercise / conversionCommon Stock 17,850 Not disclosed Not disclosed
Disclosure

SEC source: 0001673528-26-000004 · form4-01082026_090111.xml · nonDerivative · entry 1

Faga Daniel · CIK 0001673528 · Director · President, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 475,989

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:04 UTC GrantRestricted Stock Unit · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001478916-26-000001 · form4-01082026_090159.xml · derivative · entry 2

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:04 UTC GrantStock Option (right to buy) · Derivative 5,500 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001478916-26-000001 · form4-01082026_090159.xml · derivative · entry 1

Schmid John P. · CIK 0001478916 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires 2036-01-05

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:02 UTC
Orwin John ADirector
GrantRestricted Stock Unit · Derivative 6,000 $0.00 $0.00
Disclosure

SEC source: 0001477384-26-000001 · form4-01082026_090106.xml · derivative · entry 2

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

Underlying: Common Stock · 6,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:02 UTC
Orwin John ADirector
GrantStock Option (right to buy) · Derivative 8,250 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001477384-26-000001 · form4-01082026_090106.xml · derivative · entry 1

Orwin John A · CIK 0001477384 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,250

Underlying: Common Stock · 8,250 shares

Expires 2036-01-05

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
GrantStock Option (right to buy) · Derivative 23,200 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · derivative · entry 8

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,200

Underlying: Common Stock · 23,200 shares

Expires 2036-01-05

F8 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
GrantRestricted Stock Unit · Derivative 17,100 $0.00 $0.00
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · derivative · entry 7

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,100

Underlying: Common Stock · 17,100 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F7 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F7 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 5,545 $0.00 $0.00
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · derivative · entry 6

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,545

Underlying: Common Stock · 5,545 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F6 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F6 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 16:12 UTC
LOUMEAU ERIC JCHIEF LEGAL OFFICER
Exercise / conversionCommon Stock 5,545 Not disclosed Not disclosed
Disclosure

SEC source: 0001239648-26-000004 · form4-01082026_090136.xml · nonDerivative · entry 1

LOUMEAU ERIC J · CIK 0001239648 · CHIEF LEGAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,796

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:07 UTC GrantRestricted Stock Unit · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001184627-26-000001 · form4-01082026_090118.xml · derivative · entry 2

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:07 UTC GrantStock Option (right to buy) · Derivative 5,500 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001184627-26-000001 · form4-01082026_090118.xml · derivative · entry 1

FENTON DENNIS M · CIK 0001184627 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires 2036-01-05

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:05 UTC GrantRestricted Stock Unit · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001187333-26-000001 · form4-01082026_090157.xml · derivative · entry 2

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:05 UTC GrantStock Option (right to buy) · Derivative 5,500 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001187333-26-000001 · form4-01082026_090157.xml · derivative · entry 1

RENTON HOLLINGS · CIK 0001187333 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires 2036-01-05

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:08 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
GrantStock Option (right to buy) · Derivative 29,000 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001276840-26-000004 · form4-01082026_090154.xml · derivative · entry 5

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

Underlying: Common Stock · 29,000 shares

Expires 2036-01-05

F5 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2027, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:08 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
GrantRestricted Stock Unit · Derivative 21,400 $0.00 $0.00
Disclosure

SEC source: 0001276840-26-000004 · form4-01082026_090154.xml · derivative · entry 4

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,400

Underlying: Common Stock · 21,400 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F4 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F4 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2027 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:08 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 5,245 $0.00 $0.00
Disclosure

SEC source: 0001276840-26-000004 · form4-01082026_090154.xml · derivative · entry 3

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,245

Underlying: Common Stock · 5,245 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:08 UTC
MULROY DENNISCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 5,245 Not disclosed Not disclosed
Disclosure

SEC source: 0001276840-26-000004 · form4-01082026_090154.xml · nonDerivative · entry 1

MULROY DENNIS · CIK 0001276840 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,575

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:06 UTC
Jain RitaDirector
GrantRestricted Stock Unit · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001707797-26-000001 · form4-01082026_090134.xml · derivative · entry 2

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:06 UTC
Jain RitaDirector
GrantStock Option (right to buy) · Derivative 5,500 $0.00 Strike: $43.91 $0.00
Disclosure

SEC source: 0001707797-26-000001 · form4-01082026_090134.xml · derivative · entry 1

Jain Rita · CIK 0001707797 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,500

Underlying: Common Stock · 5,500 shares

Expires 2036-01-05

F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 6, 2026 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document
January 06, 2026 Filed Jan 8, 2026 21:05 UTC GrantRestricted Stock Unit · Derivative 4,000 $0.00 $0.00
Disclosure

SEC source: 0001631486-26-000001 · form4-01082026_090143.xml · derivative · entry 2

Marquet Magda · CIK 0001631486 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,000

Underlying: Common Stock · 4,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2027 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.